Back to Report Store Home

Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes

  • Published: Aug-2016
  • Report Code: GBIHC356MR
  • Report Format: pdf

Description

List of Tables

Table 1: Pain Market, Global, Categories of Pain, 2016 10

Table 2: Pain Market, Global, Data for XXX, 2016 36

Table 3: Pain Market, Global, Data for XXX 2016 37

Table 4: Pain Market, Global, Data for XXX, 2016 38

Table 5: Pain Market, Global, Data for XXX, 2016 41

Table 6: Pain Market, Global, Data for XXX, 2016 43

Table 7: Pain Market, Global, Data for XXX, 2016 44

Table 8: Pain Market, Global, Data for XXX, 2016 45

Table 9: Pain Market, Global, Data for XXX, 2016 46

Table 10: Pain Market, Global, Data for XXX, 2016 47

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$6995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$13990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$20985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards